Gevokizumab is a humanized monoclonal antibody used in the treatment of diabetes and inflammatory disorders.
Gevokizumab was developed by XOMA US LLC.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
